Home
Reinnervate

Reinnervate Market Share Analysis for November 2025

Want to better translate your discoveries into therapies? Speak to our human tissue and stem cell experts about your research challenges.

Science and Education > Biology

Domainreinnervate.com

Year Founded2002

Employees51 - 200

Annual Revenue$10M - $15M

Reinnervate

Reinnervate (including company regionals)

reinnervate.com

See more website traffic and engagement information

Reinnervate Revenue up to November 2025 is 10M - 15M

revenue generated by Reinnervate top domains

Reinnervate top domains revenue over 3 years

Revenue for Reinnervate top domains

reinnervate.com10M - 15M

See more with Sales Intelligence

Total visits to Reinnervate's top domains

Understand Reinnervate market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Reinnervate's top domains

Analyze Reinnervate engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Reinnervate's top domains

See how Reinnervate keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Reinnervate top competitors by domain

Top similar sites in November 2025, ranked by their affinity

beckmancoulter.comCompany NameBeckman Coulter, Inc.Employees> 10001HQUnited States, California, BreaAnnual revenue> $1BTotal visits110KScience and Education > Biology

Top technologies used by Reinnervate

These are the website technologies, by industry, used by Reinnervate top domains

Payment & Currencies (4)

Stripe

Email Services (2)

G Suite

Mobile (2)

Meta Viewport

Audio Video Media (1)

Vimeo

More Technologies

4

See all

News & Signals from Reinnervate

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsReproCELL Inc. acquired Reinnervate on Jan 1st '16.Recognizing the future of 3D cell culture applications for drug discovery and regenerative medicine, REPROCELL acquired Reinnervate in 2016.

NewsReinnervate partners with Catapult.Reprocell will work with Medicines Discovery Catapult’s Virtual R&D platform to predict how drugs will behave in patients during clinical trials.

NewsBiopta Ltd. merges with Reinnervate.ReproCELL has announced that two of its Group companies, Biopta and Reinnervate , will merge to form a new company, ReproCELL Europe Ltd.